Invacare is pleased to launch its Oxygen Therapy App for healthcare professionals and homecare providers in the field of Respiratory Care, in Europe. The App, which will be available via the Invacare website, is designed for use on tablets and pcs, and provides up-to-date information about oxygen therapy. The resource includes comparative studies on innovative oxygen systems and clinical evidence on Pulse Dose supplemental oxygen: valuable information that is now delivered directly to these healthcare professionals.
Specifically designed to help those treating patients with Chronic Obstructive Pulmonary Disorder (COPD), the App enables these healthcare professionals to learn more about available options for ambulatory oxygen therapy and how portable oxygen systems can help COPD patients enjoy independent living.
According to the latest estimates from the World Health Organization (WHO), 64 million people have Chronic Obstructive Pulmonary Disorder (COPD) and 3 million people die of COPD every year. The WHO predicts that COPD will become the third leading cause of death worldwide by 2030. This illness, whilst often debilitating, can be treated with a range of clinical interventions, including a well-managed oxygen supply.
Invacare’s oxygen therapy products focus on helping individuals live an active lifestyle as possible whilst using supplementary oxygen. Focussing on innovative solutions such as Oxygen Concentrators, flexible Self-Fill oxygen products and truly portable devices, Invacare aims to improve people’s lives and free them from the constraints of bottled oxygen deliveries.
To learn more about Invacare Oxygen Therapy, please visit our dedicated page
Invacare European headquarters are based in Switzerland. For more information, visit Invacare’s website: www.invacare.eu.com
Invacare is helping to raise awareness of COPD by supporting World COPD day on 20th November